Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Melero

Showing results (1-10 of 351) with videos related to

Pageof 36
Sort By:
The Journal of Experimental Medicine|November 4, 2020
4-1BB (CD137) in anticancer chimerasIgnacio Melero, Pedro Berraondo
Journal for Immunotherapy of Cancer|December 9, 2025
Reframing adjuvant immunotherapy in melanoma: all of it starts with primingPaolo A Ascierto, Ignacio Melero
The New England Journal of Medicine|February 19, 2015
Genetic basis for clinical response to CTLA-4 blockadeIgnacio Melero, Juan J Lasarte
Seminars in Oncology|May 13, 2015
Immune response regulation in the tumor microenvironment by hypoxiaSara Labiano, Asis Palazon, Ignacio Melero
Immunologic Research|October 20, 2005
The many sounds of T lymphocyte silenceIgnacio Melero, Ainhoa Arina, Lieping Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Immunotherapy of Hepatocellular Carcinoma: Facts and HopesMercedes Iñarrairaegui, Ignacio Melero, Bruno Sangro
Nature Reviews. Gastroenterology & Hepatology|October 21, 2015
Immunological landscape and immunotherapy of hepatocellular carcinomaJesús Prieto, Ignacio Melero, Bruno Sangro
Frontiers in Immunology|December 26, 2013
Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodesAlvaro Teijeira, Ana Rouzaut, Ignacio Melero
Clinical and Translational Medicine|March 30, 2025
GDF-15 blockade: A multi-directional approach to potentiate cancer immunotherapy and alleviate cancer cachexiaIgnacio Melero, Kathrin Klar, Eugen Leo
Hepatic Oncology|September 8, 2018
Immunotherapy of hepatocellular carcinomaBruno Sangro, Daniel Palmer, Ignacio Melero
Pageof 36

Showing results (1-10 of 351) with videos related to

Sort By:
Pageof 36
The Journal of Experimental Medicine|November 4, 2020
4-1BB (CD137) in anticancer chimerasIgnacio Melero, Pedro Berraondo
Journal for Immunotherapy of Cancer|December 9, 2025
Reframing adjuvant immunotherapy in melanoma: all of it starts with primingPaolo A Ascierto, Ignacio Melero
The New England Journal of Medicine|February 19, 2015
Genetic basis for clinical response to CTLA-4 blockadeIgnacio Melero, Juan J Lasarte
Seminars in Oncology|May 13, 2015
Immune response regulation in the tumor microenvironment by hypoxiaSara Labiano, Asis Palazon, Ignacio Melero
Immunologic Research|October 20, 2005
The many sounds of T lymphocyte silenceIgnacio Melero, Ainhoa Arina, Lieping Chen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Immunotherapy of Hepatocellular Carcinoma: Facts and HopesMercedes Iñarrairaegui, Ignacio Melero, Bruno Sangro
Nature Reviews. Gastroenterology & Hepatology|October 21, 2015
Immunological landscape and immunotherapy of hepatocellular carcinomaJesús Prieto, Ignacio Melero, Bruno Sangro
Frontiers in Immunology|December 26, 2013
Initial afferent lymphatic vessels controlling outbound leukocyte traffic from skin to lymph nodesAlvaro Teijeira, Ana Rouzaut, Ignacio Melero
Clinical and Translational Medicine|March 30, 2025
GDF-15 blockade: A multi-directional approach to potentiate cancer immunotherapy and alleviate cancer cachexiaIgnacio Melero, Kathrin Klar, Eugen Leo
Hepatic Oncology|September 8, 2018
Immunotherapy of hepatocellular carcinomaBruno Sangro, Daniel Palmer, Ignacio Melero
Pageof 36